Trial Profile
Magnetoencephalographic Imaging of Sleepiness: The Effect of Armodafinil in Shift Work Sleep Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2010
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary)
- Indications Circadian rhythm sleep disorders
- Focus Therapeutic Use
- 02 Apr 2010 Actual number of patients added to 24 as reported by ClinicalTrials.gov.
- 02 Apr 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 02 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.